FDA Approved Drug May Slow Beta Cell Destruction In Type 1 Diabetes Patients

New findings by UT Southwestern researchers suggest that a drug already used to treat autoimmune disorders might also help slow the destruction of insulin-producing cells in patients recently diagnosed with insulin-dependent (type 1) diabetes. In type 1 diabetes, formerly known as juvenile diabetes, cells in the pancreas called beta cells, which produce insulin, are destroyed by an autoimmune process…

Original post:
FDA Approved Drug May Slow Beta Cell Destruction In Type 1 Diabetes Patients

Related posts:

1. What Are The Different Type Of Diabetes? Diabetes mellitus mainly comes when pancreas does not produce in sufficient amounts or any of hormone insulin or when insulin is generated that does not perform out efficiently....
2. FDA Approved Leukemia Drug Shows Promising Activity In Ovarian Cancer Cells The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and...
3. FDA Approves New Drug For Rare Cancer Cutaneous T-Cell Lymphoma The US Food and Drug Administration (FDA) has approved a new drug for treating patients with the rare white blood cell cancer Cutaneous T-cell Lymphoma (CTCL); the drug Istodax (romidepsin)...
4. FDA Approves Gloucester Pharmaceuticals’ ISTODAX(R) For Patients With Cutaneous T-cell Lymphoma Gloucester Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) approved ISTODAX® (romidepsin) for the treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least...
5. FAQs About Type 2 Diabetes Cure Have you just been diagnosed with type 2 diabetes? Are you looking for a type 2 diabetes cure? Find out the truth about type 2 diabetes cure....
6. FDA Approves Gloucester Pharmaceuticals’ ISTODAX(R) For Patients With Cutaneous T-cell Lymphoma Gloucester Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) approved ISTODAX® (romidepsin) for the treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least...
7. ‘Rational Drug Design’ Identifies Fragments Of FDA-Approved Drugs Relevant To Emerging Viruses A massive, data-crunching computer search program that matches fragments of potential drug molecules to the known shapes of viral surface proteins has identified several FDA-approved drugs that could be the...
8. New Type 2 Diabetes And Obesity Treatment Approved – EndoBarrier Receives European CE Mark GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced that it has received European CE mark approval for the EndoBarrier(TM), a non-surgical therapy...
9. Echo Therapeutics Announces Positive Results Of A Clinical Study Testing Symphony(TM) TCGM System In Patients With Type 1 And Type 2 Diabetes Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System...
10. Islet Cell Transplantation In Scotland The Scottish National Blood Transfusion Service has opened a new laboratory in Edinburgh to offer around 12 people a year islet cell transplant therapy. Islet cell transplant therapy is a...
11. Genetics and Lifestyle Risk Factors for Type 2 Diabetes Type 2 Diabetes Causes - Genetics & Lifestyle Risk Factors...
12. Two Thirds Of Brits Do Not Know The Difference Between Type 1 And Type 2 Diabetes New research out today reveals that less than a third of UK residents (30 per cent) know of type 1 diabetes with a further 59 per cent confusing the autoimmune...
13. Cardiovascular Risk In Youth With Type 1 Diabetes Linked Primarily To Insulin Resistance According to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM), youth with type 1 diabetes have now been found to have...
14. Pioneering Discoveries About The Development Of Cells How does the developing pancreas in an embryo 'know' which cells are to produce insulin and which cells are to have other assignments? Researchers need to understand this if they...
15. Sitagliptin Approved As Add-on To Insulin Sitagliptin (known as Januvia) has been approved by the European Commission as an add-on to insulin (with or without metformin) for people with Type 2 diabetes who cannot control their...

« Physician Offers Tips To Avoid Flu Infection Detox Diets and Detox Facts – Why YOU should Detox. »